Literature DB >> 11564869

Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation.

M Gronda1, S Arab, B Iafrate, H Suzuki, B W Zanke.   

Abstract

The mitogen-activated protein kinases (MAPKs) are signaling molecules that become enzymatically activated through phosphorylation by diverse stimuli. Hematopoietic cytokines, growth factors, and stimulated lymphocyte antigen receptors may activate specific MAPKs by altering the balance of MAPK-activating protein kinases and the protein phosphatases that target their activation sites. Hematopoietic protein tyrosine phosphatase (HePTP) is a hematopoiesis-specific cytoplasmic protein tyrosine phosphatase whose expression is induced by mitogenic stimuli. To investigate the role of HePTP in hematopoietic development, we constructed mice deficient in this phosphatase using the technique of homologous recombination. Primary lymphocytes from HePTP(-/-) mice show enhanced activation of extracellular stimulus-regulated kinase (ERK) after both phorbol myristate acetate (PMA) and anti-CD3-mediated T-cell receptor (TCR) stimulation, suggesting a true physiological relationship between these two molecules. Activation of MEK, the physiological activator of ERK, by anti-CD3 or PMA is not affected by HePTP deletion. The distribution of hematopoietic lineages in bone marrow and peripheral blood samples and the in vitro proliferative capacity of bone marrow progenitors from HePTP deletion mice do not deviate from those of matched littermate controls. Similarly, lymphocyte activation and development are indistinguishable in HePTP(-/-) mice and controls. We conclude that HePTP is a physiological regulator of ERK on the basis of these studies and hypothesize that its deletion is well compensated for in the developing mouse through reduction of ERK targets or enhancement of physiologically opposed signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564869      PMCID: PMC99862          DOI: 10.1128/MCB.21.20.6851-6858.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles.

Authors:  C J Roberts; B Nelson; M J Marton; R Stoughton; M R Meyer; H A Bennett; Y D He; H Dai; W L Walker; T R Hughes; M Tyers; C Boone; S H Friend
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Widespread aneuploidy revealed by DNA microarray expression profiling.

Authors:  T R Hughes; C J Roberts; H Dai; A R Jones; M R Meyer; D Slade; J Burchard; S Dow; T R Ward; M J Kidd; S H Friend; M J Marton
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

3.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.

Authors:  K R Thomas; M R Capecchi
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

Review 4.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

Authors:  S K Hanks; A M Quinn; T Hunter
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

5.  MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase.

Authors:  M Muda; U Boschert; R Dickinson; J C Martinou; I Martinou; M Camps; W Schlegel; S Arkinstall
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

6.  The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation.

Authors:  Y Chu; P A Solski; R Khosravi-Far; C J Der; K Kelly
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

7.  Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts.

Authors:  K Dorfman; D Carrasco; M Gruda; C Ryan; S A Lira; R Bravo
Journal:  Oncogene       Date:  1996-09-05       Impact factor: 9.867

8.  IL-2-induced gene expression of protein-tyrosine phosphatase LC-PTP requires acidic and serine-rich regions within IL-2 receptor beta chain.

Authors:  M Adachi; T Torigoe; M Sekiya; Y Minami; T Taniguchi; Y Hinoda; A Yachi; J C Reed; K Imai
Journal:  FEBS Lett       Date:  1995-09-18       Impact factor: 4.124

9.  Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts.

Authors:  D Bokemeyer; A Sorokin; M Yan; N G Ahn; D J Templeton; M J Dunn
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

10.  Pyp1 and Pyp2 PTPases dephosphorylate an osmosensing MAP kinase controlling cell size at division in fission yeast.

Authors:  J B Millar; V Buck; M G Wilkinson
Journal:  Genes Dev       Date:  1995-09-01       Impact factor: 11.361

View more
  22 in total

1.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation.

Authors:  Eduard Sergienko; Jian Xu; Wallace H Liu; Russell Dahl; David A Critton; Ying Su; Brock T Brown; Xochella Chan; Li Yang; Ekaterina V Bobkova; Stefan Vasile; Hongbin Yuan; Justin Rascon; Sharon Colayco; Shyama Sidique; Nicholas D P Cosford; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Paul J Lombroso; Lutz Tautz
Journal:  ACS Chem Biol       Date:  2011-11-17       Impact factor: 5.100

4.  A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity.

Authors:  Ping-Yuan Wang; Pingsheng Liu; Jian Weng; Estelle Sontag; Richard G W Anderson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 5.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

6.  Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.

Authors:  Yuan-Yuan Zhang; Zi-Qing Mei; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

7.  Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.

Authors:  David A Critton; Antoni Tortajada; Geoffrey Stetson; Wolfgang Peti; Rebecca Page
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

8.  Hematopoietic protein tyrosine phosphatase mediates beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes.

Authors:  Jaclyn W McAlees; Virginia M Sanders
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

9.  Redox-regulation of Erk1/2-directed phosphatase by reactive oxygen species: role in signaling TPA-induced growth arrest in ML-1 cells.

Authors:  Kassim Traore; Rajni Sharma; Rajesh K Thimmulappa; Walter H Watson; Shyam Biswal; Michael A Trush
Journal:  J Cell Physiol       Date:  2008-07       Impact factor: 6.384

10.  The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions.

Authors:  Jennifer A Young; Amy M Becker; Jennifer J Medeiros; Virginia S Shapiro; Andrew Wang; J David Farrar; Timothy A Quill; Rob Hooft van Huijsduijnen; Nicolai S C van Oers
Journal:  Mol Immunol       Date:  2008-07-09       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.